Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Investor2014,
or anyone else, the ClinicalTrials.gov page has been updated today. Anyone want to comment on what was updated and the significance, if any?
ClinicalTrials.gov link
IMHO
Bio,
Thank you for the due diligence. Helping us all.
Bio,
I edited my post because I was not sure I was correct. So if someone, including you can repeat what I said if true, or clarify if the news today is about aducanumab or some other variant.
Thanks.
IMHO
re: 16 of 32 for example
Oops. 14 out of 32 dropped out of the 3mg, not 16. Still significant.
IMHO
re: Problem is greed
profit = premiums - cost of health, as MycroftHolmes states but...
The problems is greed.
If the cost of health goes down, it would be nice if the premiums went down so that profits stayed the same. This NEVER happens. Nothing wrong with increasing profits, at a reasonable rate or following the rate of inflation. Never happens because of greed. Human nature is difficult to regulate and control.
IMHO
Question for you and others: Do you think the inclusion/exclusion criteria would be kept private for competitive reasons? Made public only after Anavex has secured approval or other favorable financial assurance?
IMHO